Literature DB >> 28530383

Diabetes Update: Prevention and Management of Diabetes Complications.

Beth Choby1.   

Abstract

Macrovascular complications of diabetes include cardiovascular events, whereas common microvascular complications include neuropathy, retinopathy, and diabetic kidney disease. Control of hypertension and dyslipidemia is an important step in minimizing the risk of complications. Blood pressure (BP) levels should be maintained at less than 140 mm Hg systolic and less than 90 mm Hg diastolic. In older adults, medical therapy to reduce BP to less than 130/70 mm Hg is not recommended. In these patients, a systolic BP level less than 130 mm Hg has not been shown to improve atherosclerotic cardiovascular disease (ASCVD) outcomes, and a diastolic BP less than 70 mm Hg is associated with a higher mortality risk. Patients with diabetes and a history of ASCVD should be treated with high-dose statins. A combination of ezetimibe and a moderate-dose statin is an option for patients who cannot tolerate high-dose therapy. Screening for kidney disease should be performed using estimated glomerular filtration rate and urine albumin measurement. Clinicians should be familiar with the limitations of both methods. Whether patients with diabetes are at increased risk of concomitant depression is not well understood, although a link has been shown in large, observational studies. Written permission from the American Academy of Family Physicians is required for reproduction of this material in whole or in part in any form or medium.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28530383

Source DB:  PubMed          Journal:  FP Essent        ISSN: 2159-3000


  7 in total

Review 1.  Mesenchymal Stem Cells Regenerate Diabetic Foot Ulcers: A Review Article.

Authors:  Javad Verdi; Sadegh Shirian; Mahshid Saleh; Hossein Khadem Haghighian; Maria Kavianpour
Journal:  World J Plast Surg       Date:  2022-03

2.  HX-1171 attenuates pancreatic β-cell apoptosis and hyperglycemia-mediated oxidative stress via Nrf2 activation in streptozotocin-induced diabetic model.

Authors:  Jimin Kim; Su-Hyun Shin; Jong-Koo Kang; Jae Wha Kim
Journal:  Oncotarget       Date:  2018-03-23

3.  Compliance with pathology testing guidelines in Australian general practice: protocol for a secondary analysis of electronic health record data.

Authors:  Gorkem Sezgin; Andrew Georgiou; Rae-Anne Hardie; Ling Li; Lisa G Pont; Tony Badrick; Guilherme S Franco; Johanna I Westbrook; Natalie Rinehart; Adam McLeod; Christopher Pearce; Marianne Shearer; Robin Whyte; Elizabeth Deveny
Journal:  BMJ Open       Date:  2018-11-13       Impact factor: 2.692

Review 4.  SIRT1 Antagonizes Oxidative Stress in Diabetic Vascular Complication.

Authors:  Teng Meng; Weifeng Qin; Baohua Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-16       Impact factor: 5.555

5.  Danhong injection represses diabetic retinopathy and nephropathy advancement in diabetic mice by upregulating microRNA-30d-5p and targeting JAK1.

Authors:  Wei Deng; Dan Huang; HongWu Xie; LiMin Wang; Qun Shen; RongRong Zeng; YuanLian Huang; JianHua Li; Bo Yang
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

6.  Exploring the risk factors of impaired fasting glucose in middle-aged population living in South Korean communities by using categorical boosting machine.

Authors:  Haewon Byeon
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-29       Impact factor: 6.055

7.  High Glucose Aggravates Cholesterol Accumulation in Glomerular Endothelial Cells Through the LXRs/LncRNAOR13C9/ABCA1 Regulatory Network.

Authors:  Yao Wang; Shumin Xiao; Saijun Zhou; Rui Zhang; Hongyan Liu; Yao Lin; Pei Yu
Journal:  Front Physiol       Date:  2020-10-19       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.